Welshpool-based pharmaceutical group PharmAust, through its wholly owned subsidiary Mimotopes, today signed an exclusive new three-year biotech contract to supply research-grade peptides.

Welshpool-based pharmaceutical group PharmAust, through its wholly owned subsidiary Mimotopes, today signed an exclusive new three-year biotech contract to supply research-grade peptides.